HUTCHMED (China) Limited
HMDCF
$3.21
-$0.61-15.99%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -24.80% | -10.12% | 10.95% | 47.08% | 96.52% |
| Total Other Revenue | -- | -121.10% | -121.10% | -121.10% | -- |
| Total Revenue | -24.80% | -22.21% | -19.34% | 22.40% | 96.52% |
| Cost of Revenue | -18.28% | -4.28% | 12.09% | 4.63% | -1.65% |
| Gross Profit | -54.33% | -93.23% | -127.92% | 202.45% | 155.80% |
| SG&A Expenses | -15.22% | -8.60% | -1.53% | -1.85% | -2.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.78% | -16.15% | -14.58% | -8.25% | -1.74% |
| Operating Income | -337.85% | -103.32% | -21.67% | 79.80% | 104.51% |
| Income Before Tax | -57.04% | -90.72% | -75.57% | 117.81% | 129.28% |
| Income Tax Expenses | 59.50% | 6.14% | -29.98% | 43.82% | 1,693.29% |
| Earnings from Continuing Operations | -62.24% | -105.53% | -50.50% | 115.16% | 128.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -40.45% | 88.05% | 117.36% | 95.89% | 30.07% |
| Net Income | -62.56% | -105.94% | -42.64% | 115.07% | 127.93% |
| EBIT | -337.85% | -103.32% | -21.67% | 79.80% | 104.51% |
| EBITDA | -217.99% | -119.06% | -20.80% | 82.95% | 106.66% |
| EPS Basic | -62.98% | -106.18% | -40.34% | 115.18% | 128.03% |
| Normalized Basic EPS | -55.96% | -79.50% | -29.21% | 120.80% | 130.81% |
| EPS Diluted | -63.77% | -115.95% | 1.20% | 112.61% | 125.56% |
| Normalized Diluted EPS | -55.30% | -79.45% | -12.50% | 119.40% | 129.69% |
| Average Basic Shares Outstanding | 0.67% | 0.82% | 0.97% | 0.63% | 0.30% |
| Average Diluted Shares Outstanding | 1.53% | 1.14% | 0.75% | 1.12% | 1.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
